Özkan, Y. Et Al. 2008. Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS). SLEEP AND BREATHING , vol.12, no.2 , 149-154.

Özkan, Y., Firat, H., Simsek, B., Torun, M., & Yardim-Akaydin, S., (2008). Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS). SLEEP AND BREATHING , vol.12, no.2, 149-154.

Özkan, YEŞİM Et Al. "Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS)," SLEEP AND BREATHING , vol.12, no.2, 149-154, 2008

Özkan, YEŞİM Et Al. "Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS)." SLEEP AND BREATHING , vol.12, no.2, pp.149-154, 2008

Özkan, Y. Et Al. (2008) . "Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS)." SLEEP AND BREATHING , vol.12, no.2, pp.149-154.

@article{article, author={YEŞİM ÖZKAN Et Al. }, title={Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS)}, journal={SLEEP AND BREATHING}, year=2008, pages={149-154} }